SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-325800
Filing Date
2018-11-14
Accepted
2018-11-13 20:34:15
Documents
65
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d618135d10q.htm 10-Q 934809
2 EX-31.1 d618135dex311.htm EX-31.1 8337
3 EX-31.2 d618135dex312.htm EX-31.2 8301
4 EX-32.1 d618135dex321.htm EX-32.1 6030
  Complete submission text file 0001193125-18-325800.txt   4650730

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT grts-20180930.xml EX-101.INS 778447
6 XBRL TAXONOMY EXTENSION SCHEMA grts-20180930.xsd EX-101.SCH 57658
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grts-20180930_cal.xml EX-101.CAL 69374
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grts-20180930_def.xml EX-101.DEF 291305
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20180930_lab.xml EX-101.LAB 419520
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20180930_pre.xml EX-101.PRE 344407
Mailing Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608 (510) 871-6100
Gritstone Oncology, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38663 | Film No.: 181180042
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1